Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-04
DOI
10.1038/s41598-017-17376-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of AtherosclerosisSignificance
- (2016) Lea Rahtu-Korpela et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent manner
- (2016) Susan F. Fitzpatrick et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia
- (2016) Elke Marsch et al. EUROPEAN HEART JOURNAL
- The role of HIF in immunity and inflammation
- (2016) Eoin P. Cummins et al. MOLECULAR ASPECTS OF MEDICINE
- Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
- (2016) Mun Chiang Chan et al. MOLECULAR ASPECTS OF MEDICINE
- Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis
- (2016) S Neitemeier et al. Cell Death & Disease
- HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
- (2015) T. Bishop et al. CIRCULATION RESEARCH
- Muscle composition is regulated by a Lox-TGF feedback loop
- (2015) L. Kutchuk et al. DEVELOPMENT
- PHD1 regulates p53-mediated colorectal cancer chemoresistance
- (2015) S. Deschoemaeker et al. EMBO Molecular Medicine
- Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis
- (2015) Murtaza M. Tambuwala et al. JOURNAL OF CONTROLLED RELEASE
- HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond
- (2015) Patrick H. Maxwell et al. Nature Reviews Nephrology
- The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression
- (2015) Ivano Amelio et al. TRENDS IN BIOCHEMICAL SCIENCES
- Caught in the cross fire: p53 in inflammation
- (2014) Tomer Cooks et al. CARCINOGENESIS
- Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
- (2014) Zoi Michailidou et al. DIABETES
- HIF Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects Against Obesity and Metabolic Dysfunction
- (2014) L. Rahtu-Korpela et al. DIABETES
- Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
- (2014) Holger K. Eltzschig et al. NATURE REVIEWS DRUG DISCOVERY
- Over-expression of prolyl hydroxylase-1 blocks NF-κB-mediated cyclin D1 expression and proliferation in lung carcinoma cells
- (2014) Xiao Xie et al. Cancer Genetics
- Prolyl 4-hydroxylases, master regulators of the hypoxia response
- (2013) J. Myllyharju Acta Physiologica
- The impact of hypoxia on cell death pathways
- (2013) Colin R. Lenihan et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Targeting the HIF pathway in inflammation and immunity
- (2013) Carsten C Scholz et al. CURRENT OPINION IN PHARMACOLOGY
- PHD1 Links Cell-Cycle Progression to Oxygen Sensing through Hydroxylation of the Centrosomal Protein Cep192
- (2013) Sandra C. Moser et al. DEVELOPMENTAL CELL
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis
- (2013) S Keely et al. Mucosal Immunology
- Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes
- (2013) Cullen M Taniguchi et al. NATURE MEDICINE
- Regulation of IL-1 -induced NF- B by hydroxylases links key hypoxic and inflammatory signaling pathways
- (2013) C. C. Scholz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis
- (2012) A. Laitala et al. BLOOD
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway
- (2012) Azadeh Arabi et al. Nature Communications
- Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice
- (2011) Sarah R. Walmsley et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypoxia and Inflammation
- (2011) Holger K. Eltzschig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Elution Conditions for Native Co-Immunoprecipitation
- (2011) Robin Antrobus et al. PLoS One
- The Hydroxylase Inhibitor Dimethyloxallyl Glycine Attenuates Endotoxic Shock Via Alternative Activation of Macrophages and IL-10 Production by B1 Cells
- (2011) Emily Hams et al. SHOCK
- Reciprocal influence of the p53 and the hypoxic pathways
- (2011) A Sermeus et al. Cell Death & Disease
- Disruption of Hypoxia-Inducible Transcription Factor-Prolyl Hydroxylase Domain-1 (PHD-1−/−) Attenuates Ex Vivo Myocardial Ischemia/Reperfusion Injury Through Hypoxia-Inducible Factor-1α Transcription Factor and Its Target Genes in Mice
- (2010) Ram Sudheer Adluri et al. ANTIOXIDANTS & REDOX SIGNALING
- Loss of Prolyl Hydroxylase-1 Protects Against Colitis Through Reduced Epithelial Cell Apoptosis and Increased Barrier Function
- (2010) Murtaza M. Tambuwala et al. GASTROENTEROLOGY
- Reactivation of Hepatic EPO Synthesis in Mice After PHD Loss
- (2010) Y. A. Minamishima et al. SCIENCE
- Inhibition of Prolyl Hydroxylase Domain-Containing Protein Suppressed Lipopolysaccharide-Induced TNF-α Expression
- (2009) Kotaro Takeda et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH)
- (2009) James D. Webb et al. BIOCHEMICAL JOURNAL
- Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury
- (2009) Martin Schneider et al. GASTROENTEROLOGY
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Proteomics-based Identification of Novel Factor Inhibiting Hypoxia-inducible Factor (FIH) Substrates Indicates Widespread Asparaginyl Hydroxylation of Ankyrin Repeat Domain-containing Proteins
- (2008) Matthew E. Cockman et al. MOLECULAR & CELLULAR PROTEOMICS
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
- (2008) William G. Kaelin et al. MOLECULAR CELL
- Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism
- (2008) Julián Aragonés et al. NATURE GENETICS
- Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins
- (2007) K. Takeda et al. BLOOD
- Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
- (2007) Y. A. Minamishima et al. BLOOD
- The Hydroxylase Inhibitor Dimethyloxalylglycine Is Protective in a Murine Model of Colitis
- (2007) Eoin P. Cummins et al. GASTROENTEROLOGY
- Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition
- (2007) Andreas Robinson et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now